Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms

被引:16
作者
Huang, Jian [1 ]
Korsunsky, Aron [1 ]
Yazdani, Mahdieh [2 ]
Chen, Jianhan [1 ]
机构
[1] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA
[2] Merck & Co Inc, Modeling & Informat, West Point, PA 19486 USA
关键词
Transient Receptor Potential Channels; TRP channels; TRP structures; ligand binding sites; activation and gating mechanism; drug design; drug targets; RECEPTOR POTENTIAL CHANNELS; TRANSIENT RECEPTOR; ION-CHANNEL; CATION CHANNEL; CAPSAICIN RECEPTOR; HEAT ACTIVATION; COLD RECEPTOR; DICTATE SENSITIVITY; ANKYRIN REPEATS; TERMINAL DOMAIN;
D O I
10.3389/fnmol.2023.1334370
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transient receptor potential (TRP) channels are a large and diverse family of transmembrane ion channels that are widely expressed, have important physiological roles, and are associated with many human diseases. These proteins are actively pursued as promising drug targets, benefitting greatly from advances in structural and mechanistic studies of TRP channels. At the same time, the complex, polymodal activation and regulation of TRP channels have presented formidable challenges. In this short review, we summarize recent progresses toward understanding the structural basis of TRP channel function, as well as potential ligand binding sites that could be targeted for therapeutics. A particular focus is on the current understanding of the molecular mechanisms of TRP channel activation and regulation, where many fundamental questions remain unanswered. We believe that a deeper understanding of the functional mechanisms of TRP channels will be critical and likely transformative toward developing successful therapeutic strategies targeting these exciting proteins. This endeavor will require concerted efforts from computation, structural biology, medicinal chemistry, electrophysiology, pharmacology, drug safety and clinical studies.
引用
收藏
页数:18
相关论文
共 283 条
[1]   The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease [J].
Abel, M ;
Hoenderop, J ;
Bindels, R .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 (04) :295-306
[2]   TRPM4 channels in the cardiovascular system: Physiology, pathophysiology, and pharmacology [J].
Abriel, Hugues ;
Syam, Ninda ;
Sottas, Valentin ;
Amarouch, Mohamed Yassine ;
Rougier, Jean-Sebastien .
BIOCHEMICAL PHARMACOLOGY, 2012, 84 (07) :873-881
[3]   Confirmation and Expansion of the Phenotype Associated with the Recurrent p.Val837Met Variant in TRPM3 [J].
Agathe, Jean-Madeleine de Sainte ;
Van-Gils, Julien ;
Lasseaux, Eulalie ;
Arveiler, Benoit ;
Lacombe, Didier ;
Pfirrmann, Clemence ;
Raclet, Virginie ;
Gaston, Laetitia ;
Plaisant, Claudio ;
Aupy, Jerome ;
Trimouille, Aurelien .
EUROPEAN JOURNAL OF MEDICAL GENETICS, 2020, 63 (08)
[4]   Association of TRPV5, CASR, and CALCR genetic variants with kidney stone disease susceptibility in Egyptians through main effects and gene-gene interactions [J].
Ali, Fahmy T. ;
Abd El-Azeem, Eman M. ;
Hekal, Hala F. A. ;
El-Gizawy, Mayada M. ;
Sayed, Mohamed S. ;
Mandoh, AbdAllah Y. ;
Soliman, Ahmed F. .
UROLITHIASIS, 2022, 50 (06) :701-710
[5]   Case Report of Transient Neonatal Hyperparathyroidism: Medically Free Mother [J].
Almidani, Eyad ;
Elsidawi, Weam ;
Almohamedi, Abdulaziz ;
Bin Ahmed, Ibrahim ;
Alfadhel, Abdulrahman .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
[6]   Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents [J].
Andre, E. ;
Gatti, R. ;
Trevisani, M. ;
Preti, D. ;
Baraldi, P. G. ;
Patacchini, R. ;
Geppetti, P. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (06) :1621-1628
[7]   The biophysical and molecular basis of TRPV1 proton gating [J].
Aneiros, Eduardo ;
Cao, Lishuang ;
Papakosta, Marianthi ;
Stevens, Edward B. ;
Phillips, Stephen ;
Grimm, Christian .
EMBO JOURNAL, 2011, 30 (06) :994-1002
[8]   Hydrophobic Gating in Ion Channels [J].
Aryal, Prafulla ;
Sansom, Mark S. P. ;
Tucker, Stephen J. .
JOURNAL OF MOLECULAR BIOLOGY, 2015, 427 (01) :121-130
[9]   TRPM1 Is Mutated in Patients with Autosomal-Recessive Complete Congenital Stationary Night Blindness [J].
Audo, Isabelle ;
Kohl, Susanne ;
Leroy, Bart P. ;
Munier, Francis L. ;
Guillonneau, Xavier ;
Mohand-Said, Saddek ;
Bujakowska, Kinga ;
Nandrot, Emeline F. ;
Lorenz, Birgit ;
Preising, Markus ;
Kellner, Ulrich ;
Renner, Agnes B. ;
Bernd, Antje ;
Antonio, Aline ;
Moskova-Doumanova, Veselina ;
Lancelot, Marie-Elise ;
Poloschek, Charlotte M. ;
Drumare, Isabelle ;
Defoort-Dhellemmes, Sabine ;
Wissinger, Bernd ;
Leveillard, Thierry ;
Hamel, Christian P. ;
Schorderet, Daniel F. ;
De Baere, Elfride ;
Berger, Wolfgang ;
Jacobson, Samuel G. ;
Zrenner, Eberhart ;
Sahel, Jose-Alain ;
Bhattacharya, Shomi S. ;
Zeitz, Christina .
AMERICAN JOURNAL OF HUMAN GENETICS, 2009, 85 (05) :720-729
[10]   Ion Channels as Therapeutic Targets: A Drug Discovery Perspective [J].
Bagal, Sharan ;
Brown, Alan D. ;
Cox, Peter J. ;
Omoto, Kiyoyuki ;
Owen, Robert M. ;
Pryde, David C. ;
Sidders, Benjamin ;
Skerratt, Sarah E. ;
Stevens, Edward B. ;
Storer, R. Ian ;
Swain, Nigel A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) :593-624